1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY TYPE
4.3.2 MARKET SEGMENTATION BY END-USER
4.3.3 MARKET SEGMENTATION BY REGION
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 OVERVIEW
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 ONGOING US MONKEYPOX RESEARCH ACTIVITIES
9.2 GROWING DEVELOPMENT OF RAPID TESTING METHODS
9.3 RAPIDLY GROWING COMMERCIAL LABORATORY-DEVELOPED MONKEYPOX TESTING
10 MARKET GROWTH ENABLERS
10.1 INCREASING PRODUCT LAUNCHES
10.2 ADVANCES IN PCR TECHNOLOGY
10.3 MONKEYPOX ERADICATION UNLIKELY TO CONTINUE IN US
11 MARKET RESTRAINTS
11.1 GROWING ACCESS TO VACCINATION AGAINST MONKEYPOX
11.2 MONKEYPOX CASES ARE IN A SHARP DECLINE
11.3 POTENTIAL RISK OF FALSE MONKEYPOX TEST RESULTS
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.1.1 INSIGHTS BY TYPE
12.1.2 INSIGHTS BY END-USER
12.1.3 INSIGHTS BY REGION
12.2 FIVE FORCES ANALYSIS
12.2.1 THREAT OF NEW ENTRANTS
12.2.2 BARGAINING POWER OF SUPPLIERS
12.2.3 BARGAINING POWER OF BUYERS
12.2.4 THREAT OF SUBSTITUTES
12.2.5 COMPETITIVE RIVALRY
13 TESTING TYPE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 POLYMERASE CHAIN REACTION (PCR)
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.4 LATERAL FLOW ASSAY
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.5 OTHER
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
14 END-USER
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 LABORATORIES
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.4 HOSPITALS & CLINICS
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.5 OTHERS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
15 REGION
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 SOUTHERN
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.4 WESTERN
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.5 NORTHEAST
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.6 CENTRAL
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
16 COMPETITIVE LANDSCAPE
16.1 COMPETITION OVERVIEW
16.2 MARKET SHARE ANALYSIS
16.2.1 ABBOTT
16.2.2 F. HOFFMANN-LA ROCHE
16.2.3 QIAGEN
16.2.4 THERMO FISHER SCIENTIFIC
17 KEY COMPANY PROFILES
17.1 ABBOTT
17.1.1 BUSINESS OVERVIEW
17.1.2 PRODUCT OFFERINGS
17.1.3 KEY STRATEGIES
17.1.4 KEY STRENGTHS
17.1.5 KEY OPPORTUNITIES
17.2 F. HOFFMANN-LA ROCHE
17.2.1 BUSINESS OVERVIEW
17.2.2 PRODUCT OFFERINGS
17.2.3 KEY STRATEGIES
17.2.4 KEY STRENGTHS
17.2.5 KEY OPPORTUNITIES
17.3 QIAGEN
17.3.1 BUSINESS OVERVIEW
17.3.2 PRODUCT OFFERINGS
17.3.3 KEY STRATEGIES
17.3.4 KEY STRENGTHS
17.3.5 KEY OPPORTUNITIES
17.4 THERMO FISHER SCIENTIFIC
17.4.1 BUSINESS OVERVIEW
17.4.2 PRODUCT OFFERINGS
17.4.3 KEY STRATEGIES
17.4.4 KEY STRENGTHS
17.4.5 KEY OPPORTUNITIES
18 OTHER PROMINENT VENDORS
18.1 ALPHA DIAGNOSTIC
18.1.1 BUSINESS OVERVIEW
18.1.2 PRODUCT OFFERINGS
18.2 ATILABIOSYSTEMS
18.2.1 BUSINESS OVERVIEW
18.2.2 PRODUCT OFFERINGS
18.3 APPLIED DNA SCIENCES
18.3.1 BUSINESS OVERVIEW
18.3.2 PRODUCT OFFERINGS
18.4 BIOGX
18.4.1 BUSINESS OVERVIEW
18.4.2 PRODUCT OFFERINGS
18.5 BIONEER
18.5.1 BUSINESS OVERVIEW
18.5.2 PRODUCT OFFERINGS
18.6 CERTEST BIOTEC
18.6.1 BUSINESS OVERVIEW
18.6.2 PRODUCT OFFERINGS
18.7 CO-DIAGNOSTICS
18.7.1 BUSINESS OVERVIEW
18.7.2 PRODUCT OFFERINGS
18.8 CORDX
18.8.1 BUSINESS OVERVIEW
18.8.2 PRODUCT OFFERINGS
18.9 CREATIVE BIOGENE
18.9.1 BUSINESS OVERVIEW
18.9.2 PRODUCT OFFERINGS
18.10 ELABSCIENCE BIOTECHNOLOGY
18.10.1 BUSINESS OVERVIEW
18.10.2 PRODUCT OFFERINGS
18.11 LABNOVATION TECHNOLOGIES
18.11.1 BUSINESS OVERVIEW
18.11.2 PRODUCT OFFERINGS
18.12 SEEGENE
18.12.1 BUSINESS OVERVIEW
18.12.2 PRODUCT OFFERINGS
19 LABORATORY-DEVELOPED MONKEYPOX TESTS
19.1 AEGIS SCIENCES
19.1.1 BUSINESS OVERVIEW
19.1.2 PRODUCT OFFERINGS
19.2 ARUP LABORATORIES
19.2.1 BUSINESS OVERVIEW
19.2.2 PRODUCT OFFERINGS
19.3 APOSTLE DIAGNOSTICS
19.3.1 BUSINESS OVERVIEW
19.3.2 PRODUCT OFFERINGS
19.4 CALIFORNIA DEPARTMENT OF PUBLIC HEALTH
19.4.1 BUSINESS OVERVIEW
19.4.2 PRODUCT OFFERINGS
19.5 CDR COMPANIES
19.5.1 BUSINESS OVERVIEW
19.5.2 PRODUCT OFFERINGS
19.6 CIRRUSDX
19.6.1 BUSINESS OVERVIEW
19.6.2 PRODUCT OFFERINGS
19.7 CLINICAL REFERENCE LABORATORY
19.7.1 BUSINESS OVERVIEW
19.7.2 PRODUCT OFFERINGS
19.8 DEVLAB BIO
19.8.1 BUSINESS OVERVIEW
19.8.2 PRODUCT OFFERINGS
19.9 DISCOVER LABS
19.9.1 BUSINESS OVERVIEW
19.9.2 PRODUCT OFFERINGS
19.10 INTEGRITY LABORATORIES
19.10.1 BUSINESS OVERVIEW
19.10.2 PRODUCT OFFERINGS
19.11 LABORATORY CORPORATION OF AMERICA HOLDINGS
19.11.1 BUSINESS OVERVIEW
19.11.2 PRODUCT OFFERINGS
19.12 MADISON CORE LABORATORIES
19.12.1 BUSINESS OVERVIEW
19.12.2 PRODUCT OFFERINGS
19.13 MAKO MEDICAL LABORATORIES
19.13.1 BUSINESS OVERVIEW
19.13.2 PRODUCT OFFERINGS
19.14 MAYO CLINIC
19.14.1 BUSINESS OVERVIEW
19.14.2 PRODUCT OFFERINGS
19.15 QUEST DIAGNOSTICS
19.15.1 BUSINESS OVERVIEW
19.15.2 PRODUCT OFFERINGS
19.16 RAPIDBIO
19.16.1 BUSINESS OVERVIEW
19.16.2 PRODUCT OFFERINGS
19.17 SHEPARD HEALTH
19.17.1 BUSINESS OVERVIEW
19.17.2 PRODUCT OFFERINGS
19.18 SONIC HEALTHCARE
19.18.1 BUSINESS OVERVIEW
19.18.2 PRODUCT OFFERINGS
19.19 US BIOTEK LABORATORIES
19.19.1 BUSINESS OVERVIEW
19.19.2 PRODUCT OFFERINGS
19.2 UW VIROLOGY LABORATORY
19.20.1 BUSINESS OVERVIEW
19.20.2 PRODUCT OFFERINGS
20 REPORT SUMMARY
20.1 KEY TAKEAWAYS
20.2 STRATEGIC RECOMMENDATIONS
21 QUANTITATIVE SUMMARY
21.1 MARKET BY TYPE
21.2 MARKET BY END-USER
21.3 MARKET BY REGION
22 APPENDIX
22.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF US MONKEYPOX TESTING MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
EXHIBIT 3 OVERVIEW OF US MONKEYPOX TESTING MARKET (2022-2025)
EXHIBIT 4 OVERVIEW OF MONKEYPOX DIAGNOSTICS WITHIN TIME FRAMES
EXHIBIT 5 IMPACT OF ONGOING US MONKEYPOX RESEARCH ACTIVITIES
EXHIBIT 6 IMPACT OF GROWING DEVELOPMENT OF RAPID TESTING METHODS
EXHIBIT 7 IMPACT OF RAPIDLY GROWING COMMERCIAL LABORATORY-DEVELOPED MONKEYPOX TESTING
EXHIBIT 8 IMPACT OF INCREASING PRODUCT LAUNCHES
EXHIBIT 9 IMPACT OF ADVANCES IN PCR TECHNOLOGY
EXHIBIT 10 IMPACT OF MONKEYPOX ERADICATION UNLIKELY TO CONTINUE IN US
EXHIBIT 11 IMPACT OF GROWING ACCESS TO VACCINATION AGAINST MONKEYPOX
EXHIBIT 12 IMPACT OF MONKEYPOX CASES IN A SHARP DECLINE
EXHIBIT 13 US MONKEYPOX CASES
EXHIBIT 14 IMPACT OF POTENTIAL RISK OF FALSE MONKEYPOX TEST RESULTS
EXHIBIT 15 US MONKEYPOX TESTING MARKET 2022–2025 ($ THOUSAND)
EXHIBIT 16 US MONKEYPOX TESTING MARKET BY TYPE 2022-2025 (%)
EXHIBIT 17 US MONKEYPOX TESTING MARKET BY END-USER 2022-2025 (%)
EXHIBIT 18 US MONKEYPOX TESTING MARKET BY REGION 2022-2025 (%)
EXHIBIT 19 FIVE FORCES ANALYSIS 2022
EXHIBIT 20 INCREMENTAL GROWTH BY TYPE 2022 & 2025
EXHIBIT 21 US MONKEYPOX TESTING MARKET BY TYPE: INCREMENTAL GROWTH ($ THOUSAND)
EXHIBIT 22 US MONKEYPOX TESTING MARKET BY TYPE: ABSOLUTE GROWTH (%)
EXHIBIT 23 US PCR MONKEYPOX TESTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 24 US PCR MONKEYPOX TESTING MARKET 2022–2025 ($ THOUSAND)
EXHIBIT 25 US LATERAL FLOW ASSAY MONKEYPOX TESTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 26 US LATERAL FLOW ASSAY MONKEYPOX TESTING MARKET 2022–2025 ($ THOUSAND)
EXHIBIT 27 US OTHER MONKEYPOX TESTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 28 US OTHER MONKEYPOX TESTING MARKET 2022–2025 ($ THOUSAND)
EXHIBIT 29 INCREMENTAL GROWTH BY END-USER 2022 & 2025
EXHIBIT 30 US MONKEYPOX TESTING MARKET BY END-USER: INCREMENTAL GROWTH ($ THOUSAND)
EXHIBIT 31 US MONKEYPOX TESTING MARKET BY END-USER: ABSOLUTE GROWTH (%)
EXHIBIT 32 US LABORATORIES MONKEYPOX TESTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 33 US LABORATORIES MONKEYPOX TESTING MARKET 2022–2025 ($ THOUSAND)
EXHIBIT 34 US HOSPITALS & CLINICS MONKEYPOX TESTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 35 US HOSPITALS & CLINICS MONKEYPOX TESTING MARKET 2022–2025 ($ THOUSAND)
EXHIBIT 36 US INDIVIDUALS MONKEYPOX TESTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 37 US OTHER MONKEYPOX TESTING MARKET 2022–2025 ($ THOUSAND)
EXHIBIT 38 INCREMENTAL GROWTH BY REGION 2022 & 2025
EXHIBIT 39 US MONKEYPOX TESTING MARKET BY REGION: INCREMENTAL GROWTH ($ THOUSAND)
EXHIBIT 40 US MONKEYPOX TESTING MARKET BY REGION: ABSOLUTE GROWTH (%)
EXHIBIT 41 SOUTHERN US MONKEYPOX TESTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 42 SOUTHERN US MONKEYPOX TESTING MARKET 2022–2025 ($ THOUSAND)
EXHIBIT 43 WESTERN US MONKEYPOX TESTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 44 WESTERN US MONKEYPOX TESTING MARKET 2022–2025 ($ THOUSAND)
EXHIBIT 45 NORTHEAST US MONKEYPOX TESTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 46 NORTHEAST US MONKEYPOX TESTING MARKET 2022–2025 ($ THOUSAND)
EXHIBIT 47 CENTRAL US MONKEYPOX TESTING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 48 CENTRAL US MONKEYPOX TESTING MARKET 2022–2025 ($ THOUSAND)
EXHIBIT 49 US VENDORS OFFERING COMMERCIAL MONKEYPOX TESTING: MARKET DOMINANCE ANALYSIS
EXHIBIT 50 US MONKEYPOX TESTING MARKET: VENDORS OFFERING COMMERCIAL MONKEYPOX TESTING - CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 51 F. HOFFMANN-LA ROCHE : TOTAL REVENUE 2019−2021 ($ BILLION)
EXHIBIT 52 F. HOFFMANN-LA ROCHE : R&D EXPENDITURE 2019−2021 ($ BILLION)
EXHIBIT 53 THERMO FISHER SCIENTIFIC: TOTAL REVENUE 2019-2021 ($ MILLIONS)
EXHIBIT 54 THERMO FISHER SCIENTIFIC: R&D EXPENDITURE 2020-2021 ($ MILLIONS)
EXHIBIT 55 THERMO FISHER SCIENTIFIC: REVENUE BY BUSINESS SEGMENT 2020-2021 ($ MILLIONS)
EXHIBIT 56 THERMO FISHER SCIENTIFIC: REVENUE BY GEOGRAPHY 2021 ($ MILLIONS)